2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
362
THE ROLE OF THE MAR TEST IN THE IDENTIFICATION AND TREATMENT
STRATEGY SELECTION FOR MEN WITH IMMUNOLOGICAL INFERTILITY
Mirkurbanova Takhmina Khamidzoda
Fergana Medical Institute of Public Health
https://doi.org/10.5281/zenodo.15427848
Abstract.
This study explores the diagnostic significance of the Mixed Antiglobulin
Reaction (MAR) test in identifying and treating male immunological infertility.
Immunological infertility in men occurs when the div mistakenly produces antibodies
against its own sperm cells, impairing their motility, function, and fertilization capability. The
MAR test serves as a key diagnostic tool to detect the presence of such anti-sperm antibodies
and assess their impact on fertility. The research discusses the mechanism of the MAR test, its
application procedures, and how the results influence the choice of treatment strategies.
Based on the test outcomes, tailored therapeutic approaches such as immunosuppressive
therapy, antioxidant treatment, or assisted reproductive technologies can be recommended.
The use of the MAR test enables early detection of immunological factors that contribute to
infertility and provides direction for effective, individualized treatment.
Keywords
: Infertility, Immunological infertility, Antibodies, Anti-sperm antibodies,
Sperm motility, Fertilization.
РОЛЬ MAR-ТЕСТА В ВЫЯВЛЕНИИ И ВЫБОРЕ СТРАТЕГИИ ЛЕЧЕНИЯ
МУЖЧИН С ИММУНОЛОГИЧЕСКИМ БЕСПЛОДИЕМ
Аннотация.
В этом исследовании изучается диагностическая значимость
теста смешанной антиглобулиновой реакции (MAR) в выявлении и лечении мужского
иммунологического бесплодия. Иммунологическое бесплодие у мужчин возникает,
когда организм ошибочно вырабатывает антитела против собственных
сперматозоидов, нарушая их подвижность, функционирование и способность к
оплодотворению. Тест MAR служит ключевым диагностическим инструментом для
обнаружения наличия таких антиспермальных антител и оценки их влияния на
фертильность. В исследовании обсуждается механизм теста MAR, процедуры его
применения и то, как результаты влияют на выбор стратегий лечения. На основании
результатов теста можно рекомендовать индивидуальные терапевтические
подходы, такие как иммуносупрессивная терапия, антиоксидантное лечение или
вспомогательные репродуктивные технологии. Использование теста MAR позволяет
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
363
на ранней стадии выявлять иммунологические факторы, способствующие бесплодию,
и дает направление для эффективного индивидуального лечения.
Ключевые слова:
Бесплодие, Иммунологическое бесплодие, Антитела,
Антиспермальные антитела, Подвижность сперматозоидов, Оплодотворение.
Introduction
Male infertility is a growing concern in reproductive medicine, affecting nearly half of
all infertility cases. Among the various causes of male infertility, immunological factors
represent a complex and often overlooked area. Immunological infertility occurs when the
male immune system produces antibodies that mistakenly attack its own sperm, reducing their
ability to fertilize an egg. Early diagnosis and a targeted treatment plan are crucial for
managing this condition effectively. The Mixed Antiglobulin Reaction (MAR) test has
emerged as one of the most reliable diagnostic tools for identifying anti-sperm antibodies in
men suspected of having immunological infertility.
Immunological infertility is commonly associated with prior testicular trauma,
surgery, infections, or varicocele. Anti-sperm antibodies may be present in the semen, blood,
or attached to the sperm surface. These antibodies interfere with normal sperm functions such
as motility, egg penetration, and fertilization. The condition is often asymptomatic and may
only be detected when conception fails despite regular unprotected intercourse. The MAR test
provides a specific and direct method for evaluating the presence and extent of these
antibodies. The MAR test is performed by mixing the semen sample with particles coated
with anti-human immunoglobulin. If the sperm carry antibodies, the particles bind to the
sperm, forming visible clusters under a microscope. The percentage of sperm bound to
particles indicates the level of immunological activity. A result showing a high percentage of
binding typically correlates with decreased fertility potential, while a low percentage may still
allow for natural conception under certain conditions.
Based on MAR test results, clinicians can design appropriate treatment strategies. If
the antidiv levels are low, antioxidant therapy and lifestyle modifications may be sufficient.
However, in moderate to severe cases, assisted reproductive techniques are often necessary.
Intrauterine insemination (IUI) may help bypass cervical mucus containing antibodies, while
in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) offer more advanced
solutions by directly introducing sperm to the egg or injecting a single sperm into the egg,
respectively.
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
364
For some patients, immunosuppressive drugs or corticosteroids may be considered to
reduce antidiv production, although their use is controversial due to potential side effects. In
certain cases, sperm washing techniques can be employed to separate antidiv-free sperm for
use in reproductive procedures. Each treatment strategy is personalized, depending on the
MAR test outcome and the couple’s overall reproductive health. The MAR test is a valuable
diagnostic tool in the assessment of male immunological infertility. It helps determine the
presence and severity of anti-sperm antibodies and guides clinicians in selecting effective and
individualized treatment strategies. By integrating the MAR test into fertility evaluations,
healthcare providers can significantly improve the chances of successful conception in
affected couples. Continued research and clinical application of this test will further enhance
reproductive outcomes and patient care in male infertility management.
Conclusion
The Mixed Antiglobulin Reaction test plays a fundamental role in the diagnosis and
management of male immunological infertility. Its ability to detect anti-sperm antibodies with
high specificity provides critical insights into the underlying cause of unexplained male
infertility. By evaluating the extent of antidiv binding on sperm cells, the MAR test guides
clinicians in selecting the most appropriate therapeutic approach, whether it be natural
conception support, intrauterine insemination, or advanced assisted reproductive technologies
such as in vitro fertilization or intracytoplasmic sperm injection. The timely use of the MAR
test not only improves diagnostic accuracy but also enhances the effectiveness of personalized
treatment strategies. As immunological factors gain increasing attention in male infertility
cases, the MAR test remains an essential component of modern reproductive diagnostics and
care.
References:
1.
Tüttelmann, F., Ruckert, C., & Röpke, A. (2018). Diagnosis and treatment of male
infertility: a review for clinicians. Deutsches Ärzteblatt International, 115(33-34),
571–582.
2.
WHO. (2021). WHO Laboratory Manual for the Examination and Processing of
Human Semen (6th ed.). Geneva: World Health Organization.
3.
Francavilla, F., Santucci, R., Barbonetti, A., & Francavilla, S. (2007). Naturally-
occurring antisperm antibodies in men: clinical significance and therapeutic
approaches. Human Reproduction Update, 13(4), 465–484.
2025
MAY
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 5
365
4.
Krapf, J. M., & Sartor, B. M. (2019). Male Immunologic Infertility: Laboratory
Diagnosis and Treatment Options. Urologic Clinics of North America, 46(4), 487–
500.
5.
Naz, R. K. (2014). Antisperm antibodies: etiology, pathogenesis, diagnosis, and
treatment. Fertility and Sterility, 102(1), 17–26.
6.
Kamolova,
Nigora.
"FAVQULODDA
VAZIYATLARDA
IJTIMOIY
ISHCHILARNING O’RNI." Modern Science and Research 4.4 (2025): 481-484.
7.
Oribjonov, Otabek. "EARLY DETECTION AND PREVENTION OF RESPIRATORY
DISEASES AMONG RESIDENTS OF INDUSTRIAL AREAS THROUGH
RADIOLOGICAL IMAGE ANALYSIS." Modern Science and Research 4.4 (2025):
497-499.
8.
Otabek, Oribjonov. "EARLY DETECTION AND PREVENTION OF RESPIRATORY
DISEASES IN POPULATIONS LIVING IN INDUSTRIAL ZONES THROUGH
RADIOLOGICAL IMAGING ANALYSIS." Web of Medicine: Journal of Medicine,
Practice and Nursing 3.4 (2025): 148-149.
9.
Aftab, Maryam, et al. "Recent Trends and Future Directions in 3D Printing of
Biocompatible Polymers." Journal of Manufacturing and Materials Processing 9.4
(2025): 129.
